Bessemer Group
OLMA icon

Bessemer Group’s Olema Pharmaceuticals OLMA Stock Holding History

Bessemer Group’s Portfolio OLMA Stock Details OLMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$0 Buy
+26
New +$348 ﹤0.01% 2606
2022
Q2 		– Sell
-64
Closed – – 1987
2022
Q1 		$0 Hold
64
– – ﹤0.01% 1920
2021
Q4 		$1K Hold
64
– – ﹤0.01% 1818
2021
Q3 		$2K Hold
64
– – ﹤0.01% 1601
2021
Q2 		$2K Hold
64
– – ﹤0.01% 1521
2021
Q1 		$2K Buy
+64
New +$2.74K ﹤0.01% 1458

Other funds holding OLMA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.68B AUM 126.09% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
LGM
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return

Bessemer Group's OLMA Position: Q2 2026 in Review

Bessemer Group opened a new position in Olema Pharmaceuticals (OLMA) in Q2 2026: 26 shares worth $0. The stake represents ﹤0.01% of the portfolio and ranks #2606 among its holdings. This is a return to the name: Bessemer Group previously reported a position in OLMA as recently as Q1 2022.

Bessemer Group first reported a position in OLMA in Q1 2021 and has held it in 6 quarters since. The position peaked at $2K in Q3 2021. 185 funds tracked by Wall St. Rank hold OLMA as of Q2 2026.

  • Bessemer Group held 26 shares of Olema Pharmaceuticals worth $0 as of Q2 2026.
  • Olema Pharmaceuticals was a new Bessemer Group position in Q2 2026.
  • Olema Pharmaceuticals made up ﹤0.01% of Bessemer Group's portfolio in Q2 2026, its #2606 holding.
  • Bessemer Group first reported a position in Olema Pharmaceuticals in Q1 2021 and has held it in 6 quarters since.
  • Bessemer Group's Olema Pharmaceuticals position peaked at $2K in Q3 2021.
  • 185 funds tracked by Wall St. Rank held Olema Pharmaceuticals as of Q2 2026.

Based on Bessemer Group's 13F filing for Q2 2026, filed 12 Aug 2026.